Camlin Fine Sciences Q2 FY27 Results Conference Call

Key Dates

• Conference call date: November 3, 2026 (Tuesday)
• Disclosure date: November 3, 2026
• Period covered: Quarter and half year ended September 30, 2026
• Previous disclosures referenced: October 29, 2026 and November 3, 2026

Management Participants

The conference call featured the following management representatives:

• Mr. Nirmal Momaya, Managing Director
• Mr. Santosh Parab, President - Strategy & Global CFO
• Mr. Pankaj Pandey, Chief Financial Officer

Content Availability

The audio recording of the conference call is available on the Company's website at: https://www.camlinfs.com/investor-relations/home/investorcallrecording

Discussion Content

Discussions during the conference call were based on publicly available information. The company specifically states that no unpublished price sensitive information (UPSI) was discussed during these interactions.

Financial Results Reference

The conference call addressed the Un-audited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026.

Compliance Statement

The company requests that the exchange take this disclosure on record and treat it as compliance under the applicable Regulations of SEBI Listing Regulations.

Stock Exchange References

• BSE Limited: Scrip Code 532834
• National Stock Exchange of India Ltd.: Symbol CAMLINFINE, Series EQ